Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable and/or Locally Advanced Breast Cancer. The INTENS Study

NCT00314977 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00314977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable and/or Locally Advanced Breast Cancer. The INTENS Study
Lead sponsor
Radboud University Medical Center
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
Not reported
Enrollment
200 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer